Cargando…

SARS-CoV-2 infection in London, England: changes to community point prevalence around lockdown time, March–May 2020

BACKGROUND: The UK has been one of the European countries most affected by COVID-19 pandemic. The UK implemented a lockdown in March 2020, when testing policy at the time was focusing on hospitalised cases. Limited information is therefore available on the impact of the lockdown on point prevalence...

Descripción completa

Detalles Bibliográficos
Autores principales: Edelstein, Michael, Obi, Chinelo, Chand, Meera, Hopkins, Susan, Brown, Kevin, Ramsay, Mary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815898/
https://www.ncbi.nlm.nih.gov/pubmed/33004659
http://dx.doi.org/10.1136/jech-2020-214730
_version_ 1783638331273248768
author Edelstein, Michael
Obi, Chinelo
Chand, Meera
Hopkins, Susan
Brown, Kevin
Ramsay, Mary
author_facet Edelstein, Michael
Obi, Chinelo
Chand, Meera
Hopkins, Susan
Brown, Kevin
Ramsay, Mary
author_sort Edelstein, Michael
collection PubMed
description BACKGROUND: The UK has been one of the European countries most affected by COVID-19 pandemic. The UK implemented a lockdown in March 2020, when testing policy at the time was focusing on hospitalised cases. Limited information is therefore available on the impact of the lockdown on point prevalence in the community. We assessed COVID-19 point prevalence in London between early April and early May 2020, which approximately reflect infection around the time of the lockdown and 3–5 weeks into lockdown. METHODS: We tested 1064 participants of a community surveillance cohort for acute COVID-19 infection using PCR in London in April and May 2020 and described positivity as well as characteristics and symptoms of the participants. RESULTS: Point prevalence decreased from 2.2% (95% CI 1.4 to 3.5) in early April to 0.2% (95% CI 0.03 to 1.6) in early May. 22% of those who tested positive in April were asymptomatic. Extrapolation from reports of confirmed cases suggest that 5–7.6% of total infections were confirmed by testing during this period. CONCLUSION: COVID-19 point prevalence in the community sharply decreased after lockdown was implemented. This study is based on a small sample and regular seroprevalence studies are needed to better characterise population-level immunity.
format Online
Article
Text
id pubmed-7815898
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-78158982021-01-25 SARS-CoV-2 infection in London, England: changes to community point prevalence around lockdown time, March–May 2020 Edelstein, Michael Obi, Chinelo Chand, Meera Hopkins, Susan Brown, Kevin Ramsay, Mary J Epidemiol Community Health Short Report BACKGROUND: The UK has been one of the European countries most affected by COVID-19 pandemic. The UK implemented a lockdown in March 2020, when testing policy at the time was focusing on hospitalised cases. Limited information is therefore available on the impact of the lockdown on point prevalence in the community. We assessed COVID-19 point prevalence in London between early April and early May 2020, which approximately reflect infection around the time of the lockdown and 3–5 weeks into lockdown. METHODS: We tested 1064 participants of a community surveillance cohort for acute COVID-19 infection using PCR in London in April and May 2020 and described positivity as well as characteristics and symptoms of the participants. RESULTS: Point prevalence decreased from 2.2% (95% CI 1.4 to 3.5) in early April to 0.2% (95% CI 0.03 to 1.6) in early May. 22% of those who tested positive in April were asymptomatic. Extrapolation from reports of confirmed cases suggest that 5–7.6% of total infections were confirmed by testing during this period. CONCLUSION: COVID-19 point prevalence in the community sharply decreased after lockdown was implemented. This study is based on a small sample and regular seroprevalence studies are needed to better characterise population-level immunity. BMJ Publishing Group 2021-02 2020-10-01 /pmc/articles/PMC7815898/ /pubmed/33004659 http://dx.doi.org/10.1136/jech-2020-214730 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Short Report
Edelstein, Michael
Obi, Chinelo
Chand, Meera
Hopkins, Susan
Brown, Kevin
Ramsay, Mary
SARS-CoV-2 infection in London, England: changes to community point prevalence around lockdown time, March–May 2020
title SARS-CoV-2 infection in London, England: changes to community point prevalence around lockdown time, March–May 2020
title_full SARS-CoV-2 infection in London, England: changes to community point prevalence around lockdown time, March–May 2020
title_fullStr SARS-CoV-2 infection in London, England: changes to community point prevalence around lockdown time, March–May 2020
title_full_unstemmed SARS-CoV-2 infection in London, England: changes to community point prevalence around lockdown time, March–May 2020
title_short SARS-CoV-2 infection in London, England: changes to community point prevalence around lockdown time, March–May 2020
title_sort sars-cov-2 infection in london, england: changes to community point prevalence around lockdown time, march–may 2020
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815898/
https://www.ncbi.nlm.nih.gov/pubmed/33004659
http://dx.doi.org/10.1136/jech-2020-214730
work_keys_str_mv AT edelsteinmichael sarscov2infectioninlondonenglandchangestocommunitypointprevalencearoundlockdowntimemarchmay2020
AT obichinelo sarscov2infectioninlondonenglandchangestocommunitypointprevalencearoundlockdowntimemarchmay2020
AT chandmeera sarscov2infectioninlondonenglandchangestocommunitypointprevalencearoundlockdowntimemarchmay2020
AT hopkinssusan sarscov2infectioninlondonenglandchangestocommunitypointprevalencearoundlockdowntimemarchmay2020
AT brownkevin sarscov2infectioninlondonenglandchangestocommunitypointprevalencearoundlockdowntimemarchmay2020
AT ramsaymary sarscov2infectioninlondonenglandchangestocommunitypointprevalencearoundlockdowntimemarchmay2020